SCHEMBL3138697

SCHEMBL3138697

COc1cc(-c2ccc(F)c(F)c2)ccc1C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.54
CD274 Q9NZQ7 1/20 0.53
CHEK1 O14757 1/20 0.50
NEK2 P51955 1/20 0.48
KDM4E B2RXH2 3/20 0.48
APAF1 O14727 1/20 0.48
RECQL P46063 1/20 0.48
CASP6 P55212 1/20 0.48
CACNA1B Q00975 1/20 0.48
APBA1 Q02410 1/20 0.48
MCL1 Q07820 1/20 0.48
CASP8 Q14790 1/20 0.48
TNFRSF1A P19438 1/20 0.46
MAPK1 P28482 2/20 0.46
RAB9A P51151 2/20 0.46
LMNA P02545 1/20 0.46
HTT P42858 1/20 0.46
HPGD P15428 1/20 0.46
ABCB1 P08183 1/20 0.45
PPARG P37231 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2770512 0.88 ALDH1A1 (0.67) ALDH1A1CD274CHEK1NEK2KDM4E
SCHEMBL3139236 0.86 CHEK1 (0.51) CD274CHEK1KDM4ETNFRSF1AABCB1
SCHEMBL3133634 0.85 ALDH1A1 (0.56) ALDH1A1CD274CHEK1NEK2KDM4E
SCHEMBL17177740 0.84 ALDH1A1 (0.62) ALDH1A1CD274CHEK1NEK2KDM4E
SCHEMBL29936484 0.84 CD274 (0.48) ALDH1A1CD274CHEK1NEK2KDM4E
SCHEMBL10459347 0.83 ALDH1A1 (0.61) ALDH1A1CHEK1NEK2KDM4EAPAF1
SCHEMBL1921213 0.82 ALDH1A1 (0.56) ALDH1A1CHEK1NEK2KDM4EAPAF1
SCHEMBL21561215 0.82 LMNA (0.60) ALDH1A1KDM4EAPAF1RECQLCASP6
SCHEMBL3135536 0.82 CTSD (0.53) CD274TNFRSF1AHTTABCB1NPC1
SCHEMBL504872 0.81 CHEK1 (0.60) ALDH1A1CHEK1KDM4EAPAF1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100004221-A1 THIAZEPINE DERIVATIVE DAIICHI SANKYO COMPANY, LIMITED (JP) 2010-01-07 US disclosed
EP-2119719-A1 THIAZEPINE DERIVATIVE Daiichi Sankyo Company, Limited (JP) 2009-11-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100004221-A1 THIAZEPINE DERIVATIVE HSD11B1, HSD17B1, HSD3B1 ALDH1A1 28/4885CD274 4744/4885CHEK1 1983/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.